Global study finds stark differences in maternal RSV vaccine uptake

AI Summary

A global review found that maternal RSV vaccination can reduce the risk of severe disease in babies by 74%, but uptake remains low in many countries. Uptake disparities were reported among some socioeconomic and ethnic groups, people with limited healthcare access, and younger mothers.

Vaccination against a common respiratory virus during pregnancy lowers the risk of severe disease in babies by 74%, but uptake in many countries remains low, a new review suggests. The report also reveals evidence of lower uptake of the respiratory syncytial virus (RSV) vaccine among some socioeconomic and ethnic groups, those with reduced access to health care and younger mothers.